Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
MK-5108 (VX-689): Applied Aurora A Inhibition in Tumor Model
2026-07-15
MK-5108 (VX-689) delivers nanomolar-selective Aurora A kinase inhibition, enabling precise dissection of cell cycle progression and tumor cell proliferation in advanced oncology models. This article translates landmark findings in retinoblastoma into actionable workflows, troubleshooting, and research strategies that maximize the power of MK-5108 in both in vitro and in vivo settings.
-
ABT-199 (Venetoclax): Functional Genomics and Precision Apop
2026-07-15
Explore how ABT-199 (Venetoclax) empowers functional genomic screening and mechanistic study of apoptosis in hematologic malignancies. Uncover unique assay insights, advanced protocol guidance, and integration with cutting-edge death-rate analytics.
-
Formononetin Shields Neurons from Oxaliplatin Neurotoxicity
2026-07-14
The reference study identifies formononetin as a neuroprotective agent that counters oxaliplatin-induced peripheral neurotoxicity in dorsal root ganglion neurons by activating the Nrf2/HO-1 antioxidant pathway, crucially without diminishing the anticancer efficacy of chemotherapy. These findings address a longstanding challenge in oncology, offering a mechanistic basis for safer chemotherapy regimens.
-
AP20187: Next-Generation Control of 14-3-3 Pathways in Cellu
2026-07-14
Explore the advanced use of AP20187 as a chemical inducer of dimerization for precise manipulation of 14-3-3 signaling pathways. This article reveals how AP20187 uniquely bridges conditional gene therapy, autophagy research, and cancer mechanism elucidation.
-
Hyperthermia and Cisplatin Synergize via Caspase-8 Pathways
2026-07-13
This study uncovers a novel mechanism by which hyperthermia and cisplatin combination therapy enhances apoptosis and pyroptosis in cancer cells through caspase-8 accumulation and activation. The findings provide mechanistic insight into the crosstalk between ubiquitination, caspase signaling, and regulated cell death, with practical implications for optimizing combination cancer therapies.
-
Palmitic acid (Hexadecanoic Acid): Technical Use and Protoco
2026-07-13
Palmitic acid (hexadecanoic acid, SKU N2456) is a high-purity, well-characterized saturated long-chain fatty acid designed for controlled in vitro research on lipid metabolism and protein palmitoylation. It addresses workflows requiring accurate fatty acid supplementation and is unsuited for aqueous-based protocols or long-term solution storage. Proper handling and solvent selection are essential for reproducible results.
-
Gramine as a Precision Tool: New Horizons in Ferroptosis Pat
2026-07-12
Explore how Gramine, a potent ferroptosis inducer, unlocks new research directions in triple-negative breast cancer and ubiquitination pathways. This in-depth analysis offers practical assay guidance and protocol insights not found in other guides.
-
Azithromycin in Experimental Senolysis: Protocols and Implic
2026-07-10
Explore the advanced utility of Azithromycin, a macrolide antibiotic, as both an antibacterial and a potent senolytic agent. This article delivers protocol guidance and scientific insights for researchers investigating aging, bacterial infection, and drug resistance, providing a distinct perspective beyond standard translational applications.
-
Sumatriptan Succinate: Protocols for 5-HT1 Receptor Agonist
2026-07-09
Sumatriptan Succinate, a leading 5-HT1 receptor agonist, is transforming both migraine and inflammation research with its selective action and reproducible performance. This guide distills the latest evidence, offering protocol enhancements and troubleshooting insights that maximize translational impact using APExBIO’s high-quality Sumatriptan.
-
Redefining qPCR Specificity: HotStart™ Master Mix in Transla
2026-07-09
Explore how HotStart™ 2X Green qPCR Master Mix catalyzes transformative gene expression analysis for translational researchers. This article blends mechanistic insight and strategic guidance, referencing multimodal antiviral research and highlighting the evolving landscape of SYBR Green qPCR master mix innovation.
-
EdU Flow Cytometry Assay Kits (Cy3): Precision in Cell Proli
2026-07-08
EdU Flow Cytometry Assay Kits (Cy3) by APExBIO deliver denaturation-free, multiplex-ready analysis of DNA synthesis, surpassing traditional BrdU workflows in sensitivity and workflow compatibility. Their unique click chemistry enables robust cell proliferation and genotoxicity testing, streamlining advanced cell cycle analysis for translational research.
-
GSK343 (A3449): Reliable EZH2 Inhibition for Epigenetic Canc
2026-07-08
This article delivers a scenario-driven, evidence-based guide to deploying GSK343 (SKU A3449) as a selective EZH2 inhibitor in cell viability and proliferation assays. By addressing common pitfalls and comparing supplier reliability, it empowers biomedical researchers with actionable insights to ensure robust, reproducible outcomes in epigenetic cancer research.
-
Annexin V-PE Apoptosis Detection Kit: Fast, Live-Cell Analys
2026-07-07
Unlock rapid, fixation-free apoptosis detection with the Annexin V-PE Apoptosis Detection Kit, built for robust phosphatidylserine externalization assays in live cells. Discover optimized workflows, comparative advantages, and troubleshooting strategies for sensitive and reproducible cell death quantification—crucial for dissecting dynamic signaling in hematological cancer models.
-
SU6656 Src Tyrosine Kinases Inhibitor: Precision in Platelet
2026-07-07
Explore the molecular precision of SU6656 Src tyrosine kinases inhibitor in advancing both ex vivo platelet production and radiotherapy sensitization. This article delivers in-depth analysis, unique protocol insights, and actionable guidance for cancer and stem cell researchers.
-
FGFR and TGFβ/PI3K/AKT Crosstalk Regulates Periostin in HER2
2026-07-06
Labrèche et al. reveal that periostin expression in HER2-positive breast cancer cells is tightly regulated by a cross talk between FGFR, TGFβ, and PI3K/AKT signaling pathways. These findings clarify the context-dependent mechanisms underlying periostin upregulation and highlight important considerations for targeting tumor microenvironment remodeling.